OVERVIEW

Virtual Tumor Board Challenge: Navigating Treatment Selection and Sequencing in Metastatic Prostate Cancer is organized by i3 Health.

Dates Available:
November 25, 2025 - November 24, 2026

Statement of Need:
Prostate cancer is the most common cancer in men and the second most common cause of cancer death in men, accounting for 30% of new cancer diagnoses and 11% of cancer deaths in males. When diagnosed in early stages, 5- and 10-year survival rates are high; however, 5-year survival remains under 50% if disease is first detected when metastatic (Siegel et al, 2024). The last 15 years have seen significant advances in systemic therapeutic options for prostate cancer, rendering molecular testing necessary for selecting optimal therapy. Improving outcomes for patients relies on collaboration amongst the care team; pathologists have the crucial expertise for interpreting test results, while nurses play a critical role in connecting patients with support and preventing and managing adverse events. In this Virtual Tumor Board Challenge, Stephen Freedland, MD, Professor of Urology at Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Andrés Matoso, MD, Professor of Pathology, Urology, and Oncology at Johns Hopkins School of Medicine; and Jennifer Sutton, RN, BS, CCRC, Director of Nursing and Study Operations at START Carolinas, the START Center for Cancer Research, will navigate treatment selection and sequencing in metastatic prostate cancer through patient case studies.

Learning Objectives:
Upon completion of this activity, participants should be able to

Apply molecular testing and imaging results to optimize treatment selection for patients with metastatic prostate cancer
Implement evidence-based sequencing strategies for novel agents and combination regimens in metastatic prostate cancer
Integrate shared decision-making approaches into care plans, considering patient preferences and potential treatment toxicities

ACCREDITATION & CREDITS

Jointly Accredited Provider:
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:
i3 Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.

Physician Assistants/Associates:
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until 11/24/26. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners:
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Nursing Continuing Professional Development:
A maximum of 1.0 ANCC contact hour may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.8 ANCC contact hours of pharmacology credit for Advanced Practice Registered Nurses.

Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 1.0 ANCC contact hour.

1 AMA PRA Category 1 Credit™

1 MOC

1 Contact Hours

1 AAPA

FACULTY

Stephen Freedland

MDUrology

Andres Matoso

MDUrology, Pathology - Anatomic/Pathology - Clinical

Jennifer Sutton

RN, BS, CCRCNursing

TARGET AUDIENCE

PhysicianNursingOncologistsUrologistsNursesPathologistsNurse PractitionersRadiation OncologistsMedical OncologistsAdvanced Practice Providers Other Healthcare Professionals